S&P Futures
5,878.75 +32.75 (+0.56%) Dow Futures
42,508.00 +187.00 (+0.44%) Nasdaq Futures
20,653.75 +155.00 (+0.76%) Russell 2000 Futures
2,231.80 +10.30 (+0.46%) Crude Oil
68.44 -3.34 (-4.65%) Gold
2,745.10 -9.50 (-0.34%)
Olympus Corporation (OCPNF)
| Previous Close | 0.00 |
| Open | 15.70 |
| Bid | 16.77 x 40000 |
| Ask | 20.00 x 40000 |
| Day's Range | 15.70 - 15.70 |
| 52 Week Range | 12.68 - 18.50 |
| Volume | |
| Avg. Volume | 226 |
| Market Cap | 21.417B |
| Beta (5Y Monthly) | 0.62 |
| PE Ratio (TTM) | 115.25 |
| EPS (TTM) | 0.16 |
| Earnings Date | Nov 08, 2024 |
| Forward Dividend & Yield | 0.26 (1.40%) |
| Ex-Dividend Date | Mar 28, 2025 |
| 1y Target Est | N/A |
BloombergOlympus CEO Exits After Allegation He Bought Illegal Drugs
(Bloomberg) -- Olympus Corp. pushed out its chief executive officer after investigating an allegation he purchased illegal drugs, a stunning exit for the German native after less than two years at the helm.Most Read from BloombergThe Tartarian CandidateBooming Cambridge Exposes England’s Widening Wealth GapA Courtyard Apartment Building Designed for Southwest SprawlRobotaxis Are No Friend of Public TransportationArgentina Drug Trafficking Hotspot Sees Murders PlungeThe company’s shares declined
Business WireCanon Medical Systems and Olympus Announce Business Alliance regarding Endoscopic Ultrasound Systems
TOKYO, January 15, 2024--Canon Medical Systems Corporation (Canon Medical) and Olympus Corporation (Olympus), today announced that we have reached an agreement to collaborate on Endoscopic Ultrasound Systems. Canon Medical will develop and manufacture diagnostic ultrasound systems used in Endoscopic Ultrasonography1 (EUS), and Olympus will perform the sales and marketing efforts. The aim of this collaboration between Canon's Aplio i8002 diagnostic ultrasound system for EUS and Olympus' Ultrasoun
